Przegląd Dermatologiczny

Abstract

4/2022 vol. 109
Case report

Paclitaxel-induced pseudoscleroderma

  1. Dermatological Students Scientific Association, Department of Dermatology, Venereology and Allergology, Faculty of Medicine, Medical University of Gdansk, Gdansk, Poland
  2. Department and Clinic of Psychiatry, Faculty of Medicine, Medical University of Gdansk, Gdansk, Poland
  3. Department of Dermatology, Venereology and Allergology, Faculty of Medicine, Medical University of Gdansk, Gdansk, Poland
Dermatol Rev/Przegl Dermatol 2022, 109, 299-309
Online publish date: 2023/01/16
View full text
Confronting perimenopausal women’s knowledge of coronary heart disease with their health behaviours. Controversial role of hormone replacement therapy in the protection of coronary heart disease

Introduction

Pseudoscleroderma (scleroderma-like disease) is a group of rare and chronic skin conditions that mimics systemic sclerosis. The etiology of these diseases covers a wide range of causative factors, including drugs used in chemotherapy.

Case Report

A 78-year-old woman was admitted due to significant hardening of the skin in the dorsal surface of feet and distal part of the lower legs. These lesions occurred after a concluded chemotherapy with paclitaxel for right breast cancer. Treatment with pentoxifylline, topical clobetasol and 30% urea ointment was introduced. One month later an improvement in the clinical condition was observed.

Conclusions

We present a case of pseudoscleroderma caused by paclitaxel and successfully treated with pentoxifylline and topical clobetasole. Conclusion of the treatment course with paclitaxel may have positively influenced the outcome in this treatment.

Share
without publication fees
without publication fees